Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
5(45%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_2
7
64%
Ph not_applicable
1
9%
Ph phase_1
2
18%
Ph phase_3
1
9%

Phase Distribution

2

Early Stage

7

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
2(18.2%)
Phase 2Efficacy & side effects
7(63.6%)
Phase 3Large-scale testing
1(9.1%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

11

all time

Status Distribution
Active(5)
Completed(5)
Other(1)

Detailed Status

Completed5
Recruiting3
Active, not recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (18.2%)
Phase 27 (63.6%)
Phase 31 (9.1%)
N/A1 (9.1%)

Trials by Status

active_not_recruiting218%
recruiting327%
unknown19%
completed545%

Recent Activity

5 active trials
Showing 5 of 11
recruitingphase_2

Embryonal Tumor With Multilayered Rosettes

NCT06861244
active_not_recruitingphase_2

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

NCT03407144
recruitingphase_2

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

NCT06391034
active_not_recruitingphase_2

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT01154920
recruitingnot_applicable

Skin Cancer and Hyperthermia and Radiotherapy

NCT06384053
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06861244Phase 2

Embryonal Tumor With Multilayered Rosettes

Recruiting
NCT03407144Phase 2

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

Active Not Recruiting
NCT06391034Phase 2

Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

Recruiting
NCT01154920Phase 2

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Active Not Recruiting
NCT06384053Not Applicable

Skin Cancer and Hyperthermia and Radiotherapy

Recruiting
NCT03317327Phase 1

REirradiation and Programmed Cell Death Protein 1 (PD-1) Blockade On Recurrent Squamous Cell Head and Neck Tumors

Completed
NCT03715946Phase 2

Adjuvant De-Escalated Radiation + Adjuvant Nivolumab for Intermediate-High Risk P16+ Oropharynx Cancer

Completed
NCT03770689Phase 1

Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer

Completed
NCT03122509Phase 2

A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer

Completed
NCT00806117Phase 3

Comparison of Different Subsequent Treatments After Radical Surgery

Unknown
NCT00002774Phase 2

Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Completed

All 11 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
11